Skye Bioscience to Participate in Upcoming Investment Conferences
San Diego, California–(Newsfile Corp. – November 24, 2025) – Skye Bioscience, Inc. (NASDAQ: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, will participate in the following upcoming investment conferences: Citi Global Healthcare Conference (Miami)1×1 meetings: Dec. 2 Evercore Annual Healthcare Conference (Coral Gables)Fireside Chat: […]